Clinical Trials Browser

Unknown × atezolizumab × Tumor-Agnostic × Clear all

NCT03835949 2022-04-01

Study of TJ004309 in Combination With Atezolizumab (Tecentriq®) in Patients With Advanced or Metastatic Cancer

Phase 1 Unknown

Neoplasm Metastasis